3 things to know about a surface treatment to reduce implant rejection

Written by Shayna Korol | May 07, 2018 | Print  |

Researchers developed a procedure called Activated Vapor Silanization to reduce metallic biomaterial implant rejection and extend prosthesis life, according to an article in Scientific Reports.

Here are three things to know.

1. AVS involves coating the implant's surface with a layer of less than one-thousandth of a millimeter thick and covalently bonding collagen molecules naturally present in the body.

2. The researchers found that immobilizing collagen molecules on a titanium alloy surface allowed a greater number of cells to grow on the material, phys.org details.

3. Titanium and titanium alloys are among the most commonly used biomaterials for hard tissue replacement, due to their resistance to corrosion, mechanical properties and biocompatibility.

More articles on surface technology:

EIT Cellular Titanium vs. PEEK with autograft: 6 things to know

Titanium implants to dominate global plasma-sprayed coatings market: 5 insights

Meditech Spine achieves FDA clearance for new Cure LP indication: 5 key points

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months